• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼部过敏的免疫发病机制:针对不同临床实体的示意图方法

Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities.

作者信息

Leonardi Andrea, De Dominicis Chiara, Motterle Laura

机构信息

Ophthalmology Unit, Department of Neuroscience, University of Padua, Italy.

出版信息

Curr Opin Allergy Clin Immunol. 2007 Oct;7(5):429-35. doi: 10.1097/ACI.0b013e3282ef8674.

DOI:10.1097/ACI.0b013e3282ef8674
PMID:17873584
Abstract

PURPOSE OF REVIEW

The immunopathogenesis of ocular allergic disorders is generally related to the specific immunoglobulin E-mediated mast cell activation and the following cascade of inflammatory mediators. Seasonal and perennial allergic conjunctivitis, however, are the only ocular diseases to involve solely type I hypersensitivity. The other main forms, vernal and atopic keratoconjunctivitis, have a more complex immunological basis and a chronic inflammatory component. Involvement of inflammatory cells, particularly eosinophils and T cells, cytokines and proteases can lead to more serious corneal damage with vision-threatening potential.

RECENT FINDINGS

Experimental allergic conjunctival models and clinical research studies have shown that T helper type 2-related mechanisms are definitely involved in the sensitization phase of ocular allergy, however, both T helper type 1 and type 2 cytokines are overexpressed in the active disease, contributing to the development of ocular inflammation.

SUMMARY

A review of the recent literature allows us to better understand the mechanisms involved in the development of ocular allergy and to guide us toward a more schematic approach, which could possibly be useful in forming a new classification, standardizing clinical phases and individuating new treatment targets.

摘要

综述目的

眼部过敏性疾病的免疫发病机制通常与特异性免疫球蛋白E介导的肥大细胞活化以及随后的一系列炎症介质有关。然而,季节性和常年性过敏性结膜炎是仅涉及I型超敏反应的眼部疾病。其他主要形式,如春季角结膜炎和特应性角结膜炎,具有更复杂的免疫学基础和慢性炎症成分。炎症细胞,特别是嗜酸性粒细胞和T细胞、细胞因子和蛋白酶的参与可导致更严重的角膜损伤,具有威胁视力的潜在风险。

最新发现

实验性过敏性结膜模型和临床研究表明,2型辅助性T细胞相关机制肯定参与眼部过敏的致敏阶段,然而,1型和2型辅助性T细胞细胞因子在活动性疾病中均过度表达,促进眼部炎症的发展。

总结

对近期文献的综述使我们能够更好地理解眼部过敏发生发展的机制,并指导我们采用更具系统性的方法,这可能有助于形成新的分类、规范临床阶段并确定新的治疗靶点。

相似文献

1
Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities.眼部过敏的免疫发病机制:针对不同临床实体的示意图方法
Curr Opin Allergy Clin Immunol. 2007 Oct;7(5):429-35. doi: 10.1097/ACI.0b013e3282ef8674.
2
Classification of ocular allergy.眼部过敏的分类。
Curr Opin Allergy Clin Immunol. 2007 Oct;7(5):424-8. doi: 10.1097/ACI.0b013e3282ef6937.
3
Immune mechanisms in allergic eye diseases: what is new?变应性眼病的免疫机制:有哪些新进展?
Curr Opin Allergy Clin Immunol. 2009 Oct;9(5):477-81. doi: 10.1097/ACI.0b013e3283303e2e.
4
Molecular immunology of allergic conjunctivitis.过敏性结膜炎的分子免疫学。
Curr Opin Allergy Clin Immunol. 2012 Oct;12(5):534-9. doi: 10.1097/ACI.0b013e328357a21b.
5
Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis.IgE 依赖性肥大细胞活化在小鼠过敏性结膜炎模型中的关键作用。
J Allergy Clin Immunol. 2009 Oct;124(4):827-33.e2. doi: 10.1016/j.jaci.2009.06.012. Epub 2009 Aug 5.
6
Emerging drugs for ocular allergy.眼部过敏的新型药物
Expert Opin Emerg Drugs. 2005 Aug;10(3):505-20. doi: 10.1517/14728214.10.3.505.
7
Immunopathological mechanisms of eosinophilic oesophagitis.嗜酸性粒细胞性食管炎的免疫病理机制。
Allergol Immunopathol (Madr). 2008 Jul-Aug;36(4):215-27.
8
Tear cytokines in acute and chronic ocular allergic inflammation.急性和慢性眼部过敏性炎症中的泪液细胞因子
Curr Opin Allergy Clin Immunol. 2004 Oct;4(5):441-5. doi: 10.1097/00130832-200410000-00018.
9
IgE and non-IgE mechanisms in ocular allergy.眼部过敏中的IgE和非IgE机制。
Ann Allergy. 1993 Sep;71(3):296-9.
10
Clinical grading of atopic keratoconjunctivitis.特应性角结膜炎的临床分级
Curr Opin Allergy Clin Immunol. 2007 Oct;7(5):442-5. doi: 10.1097/ACI.0b013e3282efd0bf.

引用本文的文献

1
[Climate change and ocular surface diseases].[气候变化与眼表疾病]
Ophthalmologie. 2025 Jan;122(1):12-19. doi: 10.1007/s00347-024-02167-6. Epub 2025 Jan 7.
2
Allergic Conjunctivitis: Review of Current Types, Treatments, and Trends.过敏性结膜炎:当前类型、治疗方法及趋势综述
Life (Basel). 2024 May 21;14(6):650. doi: 10.3390/life14060650.
3
Vernal Keratoconjunctivitis: Immunopathological Insights and Therapeutic Applications of Immunomodulators.春季角结膜炎:免疫病理学见解及免疫调节剂的治疗应用
Life (Basel). 2024 Mar 9;14(3):361. doi: 10.3390/life14030361.
4
Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab.春季角结膜炎:当前的免疫学和临床证据以及奥马珠单抗的潜在作用
World Allergy Organ J. 2023 Jun 15;16(6):100788. doi: 10.1016/j.waojou.2023.100788. eCollection 2023 Jun.
5
Comparison of olopatadine with ketotifen for allergic conjunctivitis: a meta-analysis study.奥洛他定与酮替芬治疗过敏性结膜炎的比较:一项荟萃分析研究。
Postepy Dermatol Alergol. 2023 Apr;40(2):326-330. doi: 10.5114/ada.2023.127647. Epub 2023 May 31.
6
Prevalence of dry eye disease in the patients of allergic conjunctivitis: Hospital-based cross-sectional study.过敏性结膜炎患者干眼疾病的患病率:基于医院的横断面研究。
Indian J Ophthalmol. 2023 Apr;71(4):1495-1498. doi: 10.4103/IJO.IJO_2816_22.
7
Therapeutic Targets in Allergic Conjunctivitis.过敏性结膜炎的治疗靶点
Pharmaceuticals (Basel). 2022 Apr 28;15(5):547. doi: 10.3390/ph15050547.
8
Analysis of the Conjunctival Microbiome in Patients with Atopic Keratoconjunctivitis and Healthy Individuals.特应性角结膜炎患者与健康个体的结膜微生物组分析
Ann Dermatol. 2021 Apr;33(2):163-169. doi: 10.5021/ad.2021.33.2.163. Epub 2021 Mar 8.
9
Multiple Allergen Simultaneous Test-Immunoblot Assay for Immunoglobulin E Detection in Patients with Isolated Allergic Conjunctivitis.多重变应原同步检测-免疫印迹法检测单纯性变应性结膜炎患者的免疫球蛋白E
J Clin Med. 2021 Mar 1;10(5):960. doi: 10.3390/jcm10050960.
10
Conjunctivitis: A Systematic Review.结膜炎:一项系统评价
J Ophthalmic Vis Res. 2020 Aug 6;15(3):372-395. doi: 10.18502/jovr.v15i3.7456. eCollection 2020 Jul-Sep.